Abstract
Hepatitis B virus (HBV) DNA viral loads (VL) show wide variation between individuals with chronic hepatitis B (CHB) infection, and are used to determine treatment eligibility. There are few refined descriptions of VL distribution in CHB, and limited understanding of the biology that underpins these patterns. We set out to describe the VL distribution in independent cohorts from the UK and South Africa, to identify associated host characteristics, and to compare with VL in HIV-1 and hepatitis C (HCV) infection. We show the presence of a ‘set-point’ in chronic HBV infection and report significant differences in the viral load distribution of HBV when compared to HIV and HCV including a bimodal distribution of viral loads and a much lower median HBV viral load.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
PCM is funded by the Wellcome Trust (ref 110110). KAL is funded by the Wellcome Trust and the The Royal Society (ref 107652/Z/15/Z). LOD is funded by the NIHR.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
CONFLICT OF INTEREST: Nil
FUNDING PCM is funded by the Wellcome Trust (ref 110110). KAL is funded by the Wellcome Trust and the The Royal Society (ref 107652/Z/15/Z). LOD is funded by the NIHR.
Data Availability
The metadata underpinning this analysis are available on-line: https://figshare.com/s/cd8b046346250dd349b0 On acceptance of this manuscript for publication, the data will be made available through a permanent DOI: 10.6084/m9.figshare.11365082
